EUVIMEDEUVIMED entdecken
Crossref

Antitumor activity of anlotinib in malignant melanoma: modulation of angiogenesis and vasculogenic mimicry

Qian Yang, Qianqian Li, Hua Fan

Archives of Dermatological Research · 2024

DOI: 10.1007/s00403-024-03020-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Qian Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Hematology, People's Hospital of Leshan, 2-428 Yong'an Road, Leshan, 614000, Sichuan, People's Republic of China. yq670523…. Hauptthemen laut MEDLINE: Quinolines, Melanoma, Neovascularization, Pathologic, Indoles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuinolinesMelanomaNeovascularization, PathologicIndolesXenograft Model Antitumor AssaysCell ProliferationHuman Umbilical Vein Endothelial CellsVascular Endothelial Growth Factor Receptor-2Cell MovementHumansAnimalsMiceCell Line, TumorReceptor, Fibroblast Growth Factor, Type 1Skin NeoplasmsSignal TransductionAntineoplastic AgentsAngiogenesis InhibitorsReceptor, Platelet-Derived Growth Factor betaMice, NudeAngiogenesis

Stichwörter der Autor:innen

AngiogenesisAnlotinibMalignant melanomaMultitargeted therapyTherapeutic innovationVasculogenic mimicry

Substanzen

QuinolinesanlotinibIndolesVascular Endothelial Growth Factor Receptor-2Receptor, Fibroblast Growth Factor, Type 1Antineoplastic AgentsFGFR1 protein, humanAngiogenesis InhibitorsReceptor, Platelet-Derived Growth Factor betaKDR protein, human

Autor:innen und Institutionen

  • Department of Oncology and Hematology, People's Hospital of Leshan, 2-428 Yong'an Road, Leshan, 614000, Sichuan, People's Republic of China. yq670523405@126.com.
  • Department of General Medical, People's Hospital of Leshan, Leshan, 614000, People's Republic of China.
  • Department of Oncology and Hematology, People's Hospital of Leshan, 2-428 Yong'an Road, Leshan, 614000, Sichuan, People's Republic of China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yang, Q., Li, Q., & Fan, H. (2024). Antitumor activity of anlotinib in malignant melanoma: modulation of angiogenesis and vasculogenic mimicry. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03020-1

Vancouver

Yang Q, Li Q, Fan H. Antitumor activity of anlotinib in malignant melanoma: modulation of angiogenesis and vasculogenic mimicry. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-03020-1

BibTeX
@article{Yang2024,
  author = {Yang, Qian and Li, Qianqian and Fan, Hua},
  title = {Antitumor activity of anlotinib in malignant melanoma: modulation of angiogenesis and vasculogenic mimicry},
  journal = {Archives of Dermatological Research},
  year = {2024},
  doi = {10.1007/s00403-024-03020-1}
}
Kostenlos starten →